SEHK:3933Pharmaceuticals
United Laboratories International (SEHK:3933) Stock Valuation After New TUL321 Clinical Trial Approval
Clinical trial approval for TUL321 puts United Laboratories in focus
United Laboratories International Holdings (SEHK:3933) has received approval from China's National Medical Products Administration to begin clinical trials for TUL321, an autoimmune drug that already holds U.S. FDA Investigational New Drug clearance.
See our latest analysis for United Laboratories International Holdings.
Those clinical trial and buyback announcements come after a tough spell for the stock. The 1-year total...